SCHEDULE 13G/A 0000898432-24-000110 0001953768 XXXXXXXX LIVE 2 Common Stock, par value $0.0001 per share 12/31/2024 0001840425 Bellevue Life Sciences Acquisition Corp. 079174108 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 Rule 13d-1(d) Bellevue Global Life Science Investors, LLC DE 1355000.00 0.00 1355000.00 0.00 1355000.00 N 58.4 OO The number of shares reported in Rows 5 and 7 represent shares of common stock held by Bellevue Global Life Sciences Investors, LLC, the sponsor of the Issuer (the "Sponsor"), including 34,500 shares held in escrow until the consummation of an initial business combination for the benefit of Chardan Capital Markets, LLC, the representative of the underwriters of the initial public offering. The general partner of the Sponsor is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor. The percentage in Row 11 is based on a total of 2,319,752 shares outstanding of the Issuer as of December 31, 2024. BCM Europe AG V8 680000.00 0.00 680000.00 0.00 680000.00 N 29.3 OO The number of shares reported in Rows 5 and 7 represent shares from 310,000 private placement units and 370,000 shares of common stock eligible to be converted by BCM Europe AG ("BCME") as a result of the promissory note between the Sponsor and BCME. The promissory note between the Sponsor and BCME is convertible at the election of either the Sponsor or BCME on or after the commencement of the Issuer's initial public offering into (i) 310,000 private placement units held by the Sponsor, (ii) 370,000 founder shares held by the Sponsor, and (iii) 60,000 warrants held by the Sponsor. BCME is a wholly-owned subsidiary of Bellevue Capital. Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor. The percentage in Row 11 is based on a total of 2,319,752 shares outstanding of the Issuer as of December 31, 2024. Bellevue Capital Management LLC WA 2035000.00 0.00 2035000.00 0.00 2035000.00 N 87.7 OO The number of shares reported in Rows 5 and 7 represent (1) shares of common stock held by the Sponsor, and (2) the shares eligible for conversion by BCME. The general partner of the Sponsor is Bellevue Capital and BCME is a wholly-owned subsidiary of Bellevue Capital. Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor. The percentage in Row 11 is based on a total of 2,319,752 shares outstanding of the Issuer as of December 31, 2024. Kuk Hyoun Hwang M5 2035000.00 0.00 2035000.00 0.00 2035000.00 N 87.7 IN The number of shares reported in Rows 5 and 7 represent (1) shares of common stock held by the Sponsor; and (2) the shares eligible for conversion by BCME. The general partner of the Sponsor is Bellevue Capital and BCME is a wholly-owned subsidiary of Bellevue Capital. Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor. The percentage in Row 11 is based on a total of 2,319,752 shares outstanding of the Issuer as of December 31, 2024. Bellevue Life Sciences Acquisition Corp. 10900 NE 4th Street, Suite 2300, Bellevue, WA 98004 Bellevue Global Life Science Investors, LLC (the "Sponsor") BCM Europe AG ("BCME") Bellevue Capital Management LLC ("Bellevue Capital") Kuk Hyoun Hwang The address for these entities and this individual is: c/o Bellevue Life Sciences Acquisition Corp. 10900 NE 4th Street Suite 2300 Bellevue, WA 98004 Sponsor: Delaware BCME: Switzerland Bellevue Capital: Washington Kuk Hyoun Hwang: Republic of Korea Y See Row 9 on the cover pages hereto See Row 11 on the cover pages hereto See Row 5 on the cover pages hereto See Row 6 on the cover pages hereto See Row 7 on the cover pages hereto See Row 8 on the cover pages hereto Y Y Y Y Y Y Exhibit 99.1 Joint Filing Agreement Bellevue Global Life Science Investors, LLC /s/ Kuk Hyoun Hwang 02/11/2025 BCM Europe AG /s/ Kuk Hyoun Hwang 02/11/2025 Bellevue Capital Management LLC /s/ Kuk Hyoun Hwang 02/11/2025 Kuk Hyoun Hwang /s/ Kuk Hyoun Hwang 02/11/2025